Next-generation sequencing (NGS) is a powerful, massively parallel sequencing technology that has transformed the biological sciences. By offering ultra-high throughput, scalability, and speed, NGS has enabled researchers to delve deeper into complex genomics questions and study biological systems in unprecedented detail. With the ability to determine the order of nucleotides in entire genomes or targeted regions of DNA or RNA, NGS has become an essential tool for labs worldwide.
The rapid advancements in next-generation sequencing (NGS) platforms have provided a competitive edge to market players, allowing them to focus on R&D efforts and develop new products. Revolutionary platforms such as PromethION (Oxford Nanopore Technologies), Ion Torrent Genexus Dx Integrated Sequencer (Thermo Fisher), Seq 100 (mina), and Ion GeneStudio S5 System (Thermo Fisher) have emerged as game changers in the market, enabling researchers to delve deeper into complex genomics questions.
However, the adoption of NGS in developing nations across Africa and Asia is hindered by end-user budget constraints. Despite continuous efforts by government and private bodies to provide funds for research, research and academic institutes in these regions often face budget constraints when purchasing and using advanced and premium-priced equipment and technologies. This restraint impedes the installation and expansion of advanced research facilities in academic and research institutes, hindering the widespread adoption of NGS in these regions.
The advancements in NGS platforms have revolutionized the biological sciences, providing ultra-high throughput, scalability, and speed, allowing labs to perform various applications and study biological systems at a level never before possible. In recent years, prominent market players have introduced new technologies, providing an immediate competitive edge to players.
Next-generation sequencing (NGS) Market has revolutionized the field of genomics, enabling researchers to delve deeper into complex genomics questions and study biological systems at an unprecedented level of detail. The continuous advancements in NGS platforms have opened up new avenues for precision medicine and molecular diagnostics, providing an immediate competitive edge to market players. However, the adoption of NGS in developing nations is hindered by budget constraints, which limit the installation and expansion of advanced research facilities.
Author's Detail
Supriya R Ghadge, LinkedIn
I am working as a Senior Research Analyst, mainly involved in conducting market research in the Information and Communication, and Technology domain. Skilled in Secondary Research, Primary Research, Data Analytics Research approaches with extensive experience providing first-class results. Highly focused, have analytical skills, and synergetic with positive energizers. Meets job demands and deadlines through diligent work-ethic and dedication to quality. Works with clients to determine requirements and provide excellent service.
Interested in a similar analysis for your market? Our experts can deliver a customized report.
Contact Our ExpertsExplore all published articles across 30+ industry verticals.
View All Articles